The Peptide Research Wiki
for Science-Based Information
Evidence-based profiles for BPC-157, semaglutide, GHK-Cu, and 74 more research compounds — with PubMed citations, mechanism breakdowns, and a free reconstitution calculator.
All data is provided for laboratory research purposes only. Not for human or animal consumption. All referenced compounds are research reagents.
Browse Peptides by Research Area
Most-Researched Compounds
BPC-157
Tissue RepairBody Protective Compound-157 (BPC-157) is a synthetic pentadecapeptide derived from gastric proteins that has demonstrated notable reparative and anti-inflammatory properties across diverse preclinica…
Semaglutide
MetabolicGlucagon-like peptide-1 (GLP-1) receptor agonists are widely used for the management of obesity; however, respiratory complications are rarely documented. A 40-year-old person without diabetes with ob…
CJC-1295
Growth Hormone SecretagogueThe pursuit of pharmacological enhancement in sport has evolved from the widespread use of anabolic-androgenic steroids (AAS) to novel agents such as peptides and peptide analogues. Marketed as more s…
Epitalon
Anti-AgingEpitalon, a naturally occurring tetrapeptide, is known for its anti-aging effects on mammalian cells. This happens through the induction of telomerase enzyme activity, resulting in the extension of te…
Semax
NeurologicalAlzheimer's disease, first described over a century ago, is currently among the most common neurodegenerative diseases whose significance is increasingly growing with the aging of populations. Through…
Tirzepatide
MetabolicINTRODUCTION: Tirzepatide has been associated with significant reductions in body weight in randomized clinical trials. However, real-world evidence evaluating the multisystemic effects of tirzepatide…
Browse by What You're Studying
Find the right compounds faster. Each goal links directly to the relevant category in the compound library.
Compound Comparisons
Structured mechanism comparisons for the most-searched compound pairs — receptor pharmacology, pharmacokinetics, and published study data.
Latest from the research blog
Plain-English summaries of recent peptide research, with primary citations.
What Is the FDA 503A Bulk Drug Substance List? A Researcher's Guide
FDA 503A bulk drug substance list framework and PCAC category designations for peptide research compounding access.
FDA PCAC July 2026: 29 Days Out — What Researchers Need to Know Before the Hearing
The FDA Pharmacy Compounding Advisory Committee convenes July 23–24, 2026 to rule on 503A status for BPC-157, TB-500, KPV, MOTS-c, DSIP, Semax, and Epitalon. Here is where each compound stands with 29 days to go.
Peptides for Cardiovascular Research: Vasodilatory, Cardioprotective & Metabolic Compounds Ranked
7 compounds studied across vasodilatory, cardioprotective, and GLP-1 cardiac outcome research — with 3 published CVOTs and Phase 3 mitochondrial trial data ranked by evidence depth.
Liraglutide Research Profile: First-Generation GLP-1 Agonist Pharmacology
2 FDA approvals, a 13-hour half-life from C16 palmitoyl acylation, and LEADER trial MACE data — here's what the liraglutide evidence base shows about GLP-1 receptor agonist pharmacology.
How to Reconstitute BPC-157: Step-by-Step Research Guide
Step-by-step guide to reconstituting lyophilized BPC-157 powder for preclinical research: bacteriostatic water volumes, concentration tables, storage conditions, and draw-volume calculations — with the reconstitution calculator.
CJC-1295 Research Profile: GHRH Analogue Mechanism & Half-Life Data
CJC-1295 is a GHRH(1-29) analogue with DPP-IV-resistant substitutions extending its half-life to ~30 min. Published PK data show dose-dependent GH peaks and IGF-1 elevation lasting 6 days.
Volumetric Reconstitution Calculator
Enter your vial parameters — the syringe updates live. U-100 and tuberculin configurations.